Use of levothyroxine in the management of hypothyroidism: A historical perspective

The thyroid operates within a complex system of homeostatic regulation, where the level of thyrotropin (TSH) influences the rate of secretion of the principal thyroid hormones, thyroxine (T4) and triiodothyronine (T3). The devastating consequences of untreated thyroid dysfunction have been evident f...

Full description

Bibliographic Details
Main Authors: George J. Kahaly, Ulrike Gottwald-Hostalek
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.1054983/full
_version_ 1828157751042244608
author George J. Kahaly
Ulrike Gottwald-Hostalek
author_facet George J. Kahaly
Ulrike Gottwald-Hostalek
author_sort George J. Kahaly
collection DOAJ
description The thyroid operates within a complex system of homeostatic regulation, where the level of thyrotropin (TSH) influences the rate of secretion of the principal thyroid hormones, thyroxine (T4) and triiodothyronine (T3). The devastating consequences of untreated thyroid dysfunction have been evident for centuries. Indeed, sources from antiquity described goitre and cretinism, two of the clinical sequelae of untreated overt thyroid disease. It was not until the first part of the 19th century that goitre and cretinism were first associated with iodine status; however, the endocrine function of the thyroid was not clearly identified until the early part of the 20th century. Three principal innovations in the 20th century supported the use of levothyroxine (LT4) replacement therapy for the management of hypothyroidism: a practical technique for the synthesis of LT4 suitable to support pharmaceutical use (late 1940s), the discovery that LT4 is converted to the active thyroid hormone, T3, in the peripheral tissues (1970), and the development of robust and sensitive assay methodology for measuring thyroid hormones in the blood (1960 onwards). Synthetic LT4, titrated to bring the level of TSH within a predefined “normal” reference range, is now established as the mainstay of treatment for hypothyroidism, and provides adequate restoration of thyroid hormone function for most people with this condition. Future research will explore further the nuances of the hypothalamic-pituitary-thyroid axis, and the place, if any, for T3 within the management of thyroid dysfunction.
first_indexed 2024-04-11T23:34:11Z
format Article
id doaj.art-0cf9effbe2e047efaa9a2ba2a19ee6e3
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-11T23:34:11Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-0cf9effbe2e047efaa9a2ba2a19ee6e32022-12-22T03:56:59ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-11-011310.3389/fendo.2022.10549831054983Use of levothyroxine in the management of hypothyroidism: A historical perspectiveGeorge J. Kahaly0Ulrike Gottwald-Hostalek1Department of Medicine I, Johannes Gutenberg University (JGU) Medical Center, Mainz, GermanyResearch and Development, Merck Healthcare KGaA, Darmstadt, GermanyThe thyroid operates within a complex system of homeostatic regulation, where the level of thyrotropin (TSH) influences the rate of secretion of the principal thyroid hormones, thyroxine (T4) and triiodothyronine (T3). The devastating consequences of untreated thyroid dysfunction have been evident for centuries. Indeed, sources from antiquity described goitre and cretinism, two of the clinical sequelae of untreated overt thyroid disease. It was not until the first part of the 19th century that goitre and cretinism were first associated with iodine status; however, the endocrine function of the thyroid was not clearly identified until the early part of the 20th century. Three principal innovations in the 20th century supported the use of levothyroxine (LT4) replacement therapy for the management of hypothyroidism: a practical technique for the synthesis of LT4 suitable to support pharmaceutical use (late 1940s), the discovery that LT4 is converted to the active thyroid hormone, T3, in the peripheral tissues (1970), and the development of robust and sensitive assay methodology for measuring thyroid hormones in the blood (1960 onwards). Synthetic LT4, titrated to bring the level of TSH within a predefined “normal” reference range, is now established as the mainstay of treatment for hypothyroidism, and provides adequate restoration of thyroid hormone function for most people with this condition. Future research will explore further the nuances of the hypothalamic-pituitary-thyroid axis, and the place, if any, for T3 within the management of thyroid dysfunction.https://www.frontiersin.org/articles/10.3389/fendo.2022.1054983/fulllevothyroxinethyroxinehypothyroidismthyroid glandhistory of medicine
spellingShingle George J. Kahaly
Ulrike Gottwald-Hostalek
Use of levothyroxine in the management of hypothyroidism: A historical perspective
Frontiers in Endocrinology
levothyroxine
thyroxine
hypothyroidism
thyroid gland
history of medicine
title Use of levothyroxine in the management of hypothyroidism: A historical perspective
title_full Use of levothyroxine in the management of hypothyroidism: A historical perspective
title_fullStr Use of levothyroxine in the management of hypothyroidism: A historical perspective
title_full_unstemmed Use of levothyroxine in the management of hypothyroidism: A historical perspective
title_short Use of levothyroxine in the management of hypothyroidism: A historical perspective
title_sort use of levothyroxine in the management of hypothyroidism a historical perspective
topic levothyroxine
thyroxine
hypothyroidism
thyroid gland
history of medicine
url https://www.frontiersin.org/articles/10.3389/fendo.2022.1054983/full
work_keys_str_mv AT georgejkahaly useoflevothyroxineinthemanagementofhypothyroidismahistoricalperspective
AT ulrikegottwaldhostalek useoflevothyroxineinthemanagementofhypothyroidismahistoricalperspective